Authors: FAAIJ RA BURGGRAAF J SCHOEMAKER HC STIEKEMA J SIEGERT C COHEN AF

Citation: Ra. Faaij et al., THE INFLUENCE OF RENAL-FUNCTION ON THE PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF ORG 31540 SR90107A/, Thrombosis and haemostasis, 1997, pp. 379-379

Authors: BEIJERING RJR VANOLDEN RW STIEKEMA J TENCATE JW

Citation: Rjr. Beijering et al., PENTASACCHARIDE IN HEMODIALYSIS - A DOSE-FINDING STUDY, Thrombosis and haemostasis, 1997, pp. 1176-1176

Authors: FAAIJ RA BURGGRAAF J SCHOEMAKER HC STIEKEMA J COHEN AF

Citation: Ra. Faaij et al., INTERACTION STUDY BETWEEN ORG 31540 SR90107A (SC) AND ORAL WARFARIN IN HEALTHY-VOLUNTEERS/, Thrombosis and haemostasis, 1997, pp. 2007-2007

Authors: BREITZ H SELLER C WEIDEN P APPELBAUM J RATLIFF B STIEKEMA J KLEIN J RUPPEL S DEJAGER R

Citation: H. Breitz et al., RE-186 LABELED 16.88-IGM AND 88BV59 IGG HUMAN-ANTIBODY STUDIES TO ASSESS POTENTIAL FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000100-160000100

Authors: ROISE O NURMOHAMED M REIJNDERS P TOUZARD R STIEKEMA J BACHMAN F BERGQVIST D BULLER H HIRSH J MAGNANI H

Citation: O. Roise et al., A MULTICENTER, RANDOMIZED, ASSESSOR-BLIND, PILOT-STUDY COMPARING THE EFFICACY IN THE PROPHYLAXIS OF DVT AND THE SAFETY OF ORGARAN(R) (ORG-10172), FRAGMIN(R), CLEXANE(R) LOVENOX(R) IN PATIENTS UNDERGOING SURGERY FOR A FRACTURED HIP, Thrombosis and haemostasis, 69(6), 1993, pp. 620-620